Period Ending | Feb 29, 2012 | Nov 30, 2011 | Aug 31, 2011 | May 31, 2011 |
---|
Total Revenue
|
4,748,000
|
2,439,000
|
2,247,000
|
3,608,000
| Cost of Revenue | 2,043,000 | 1,343,000 | 1,275,000 | 1,635,000 | |
Gross Profit
|
2,705,000
|
1,096,000
|
972,000
|
1,973,000
| |
|
Operating Expenses |
|
Research Development | 353,000 | 351,000 | 403,000 | 360,000 |
|
Selling General and Administrative | 543,000 | 500,000 | 647,000 | 591,000 |
|
Non Recurring |
-
|
-
| (8,000) | 1,000 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,809,000
|
245,000
|
(70,000)
|
1,021,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (17,000) | 12,000 | 21,000 | 2,000 |
|
Earnings Before Interest And Taxes | 1,792,000 | 257,000 | (49,000) | 1,023,000 |
|
Interest Expense | 47,000 | 53,000 | 45,000 | 35,000 |
|
Income Before Tax | 1,745,000 | 204,000 | (94,000) | 988,000 |
|
Income Tax Expense | 540,000 | 70,000 | 3,000 | 276,000 |
|
Minority Interest | (1,000) | (8,000) | (14,000) | (20,000) |
|
|
|
Net Income From Continuing Ops | 1,204,000 | 126,000 | (111,000) | 692,000 | |
|
Non-recurring Events |
|
Discontinued Operations | 7,000 |
-
| (1,000) |
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,211,000
|
126,000
|
(112,000)
|
692,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,211,000
|
126,000
|
(112,000)
|
692,000
|
|